Interleukin‐33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukin‐33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development

Published:2019-12-05 Issue:5 Volume:146 Page:1421-1434
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Qi Lu¹,Zhang Qiuyan¹,Miao Yuhui¹,Kang Wenyao¹,Tian Zhigang¹,Xu Damo²,Xiao Weihua¹,Fang Fang¹^ORCID

Affiliation:

1. Department of Oncology of The First Affiliated Hospital, Division of Life Sciences and Medicine, Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic DiseaseUniversity of Science and Technology of China Hefei China

2. School of MedicineShenzhen University Shenzhen China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32779

Reference49 articles.

1. Cancer metastases: challenges and opportunities

2. Role of tumor microenvironment in tumorigenesis

3. The Basis of Oncoimmunology

4. HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins

5. The lung metastatic niche

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-33/ST2 Signaling and its Correlation with Macrophage Heterogeneity and Clinicopathologic Features in Human Intrahepatic Cholangiocarcinoma;Current Cancer Drug Targets;2024-11

2. Unveiling the multifaceted antitumor effects of interleukin 33;Frontiers in Immunology;2024-05-31

3. Determining the toxicological effects of indoor air pollution on both a healthy and an inflammatory-comprised model of the alveolar epithelial barrier in vitro;Particle and Fibre Toxicology;2024-05-17

4. Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells;Cancer Cell;2024-04

5. Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer;EMBO Molecular Medicine;2024-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3